cabergoline has been researched along with Endometrial Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erdenebaatar, C; Honda, R; Katabuchi, H; Monsur, M; Ohba, T; Saito, F; Tashiro, H; Yamaguchi, M | 1 |
1 other study(ies) available for cabergoline and Endometrial Neoplasms
| Article | Year |
|---|---|
Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate.
Topics: Adult; Antineoplastic Agents, Hormonal; Cabergoline; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hyperprolactinemia; Lectins, C-Type; Medroxyprogesterone Acetate; Retrospective Studies; Young Adult | 2018 |